Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma

Completed · Phase 1/Phase 2

Conditions studied: Melanoma (Skin)

In brief

RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. Photodynamic therapy may be effective in treating melanoma. PURPOSE: Phase I/II trial to study the effectiveness of photodynamic therapy in treating patients who have stage III or stage IV melanoma.

Key facts

Study ID

NCT00007969

Run by

QLT Inc.

Starts

2000-10-01

Last updated by the study team

2013-11-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Colorado Cancer Center — Denver, Colorado, United States
• Mount Sinai Comprehensive Cancer Center at Aventura — Aventura, Florida, United States
• Mount Sinai Comprehensive Cancer Center — Miami Beach, Florida, United States
• Barbara Ann Karmanos Cancer Institute — Detroit, Michigan, United States
• Missouri Baptist Cancer Center — St Louis, Missouri, United States
• University of Pittsburgh Cancer Institute — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.